These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
259 related articles for article (PubMed ID: 9087440)
1. Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. Katahira J; Inoue N; Horiguchi Y; Matsuda M; Sugimoto N J Cell Biol; 1997 Mar; 136(6):1239-47. PubMed ID: 9087440 [TBL] [Abstract][Full Text] [Related]
2. Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. Katahira J; Sugiyama H; Inoue N; Horiguchi Y; Matsuda M; Sugimoto N J Biol Chem; 1997 Oct; 272(42):26652-8. PubMed ID: 9334247 [TBL] [Abstract][Full Text] [Related]
3. Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer. Cocco E; Casagrande F; Bellone S; Richter CE; Bellone M; Todeschini P; Holmberg JC; Fu HH; Montagna MK; Mor G; Schwartz PE; Arin-Silasi D; Azoudi M; Rutherford TJ; Abu-Khalaf M; Pecorelli S; Santin AD BMC Cancer; 2010 Jul; 10():349. PubMed ID: 20598131 [TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of the 3' half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity. Hanna PC; Wnek AP; McClane BA J Bacteriol; 1989 Dec; 171(12):6815-20. PubMed ID: 2556374 [TBL] [Abstract][Full Text] [Related]
5. Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region. Hanna PC; Mietzner TA; Schoolnik GK; McClane BA J Biol Chem; 1991 Jun; 266(17):11037-43. PubMed ID: 1645721 [TBL] [Abstract][Full Text] [Related]
6. Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin. Casagrande F; Cocco E; Bellone S; Richter CE; Bellone M; Todeschini P; Siegel E; Varughese J; Arin-Silasi D; Azodi M; Rutherford TJ; Pecorelli S; Schwartz PE; Santin AD Cancer; 2011 Dec; 117(24):5519-28. PubMed ID: 21692061 [TBL] [Abstract][Full Text] [Related]
7. RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin. Shrestha A; Mehdizadeh Gohari I; McClane BA mBio; 2019 Dec; 10(6):. PubMed ID: 31848291 [No Abstract] [Full Text] [Related]
8. Clostridium perfringens enterotoxin fragment removes specific claudins from tight junction strands: Evidence for direct involvement of claudins in tight junction barrier. Sonoda N; Furuse M; Sasaki H; Yonemura S; Katahira J; Horiguchi Y; Tsukita S J Cell Biol; 1999 Oct; 147(1):195-204. PubMed ID: 10508866 [TBL] [Abstract][Full Text] [Related]
11. Rapid eradication of colon carcinoma by Clostridium perfringens Enterotoxin suicidal gene therapy. Pahle J; Menzel L; Niesler N; Kobelt D; Aumann J; Rivera M; Walther W BMC Cancer; 2017 Feb; 17(1):129. PubMed ID: 28193196 [TBL] [Abstract][Full Text] [Related]
12. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Long H; Crean CD; Lee WH; Cummings OW; Gabig TG Cancer Res; 2001 Nov; 61(21):7878-81. PubMed ID: 11691807 [TBL] [Abstract][Full Text] [Related]
13. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin. Li X; Saeki R; Watari A; Yagi K; Kondoh M Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339 [TBL] [Abstract][Full Text] [Related]
14. Identification of a claudin-4 residue important for mediating the host cell binding and action of Clostridium perfringens enterotoxin. Robertson SL; Smedley JG; McClane BA Infect Immun; 2010 Jan; 78(1):505-17. PubMed ID: 19884339 [TBL] [Abstract][Full Text] [Related]
15. A claudin 3 and claudin 4-targeted Clostridium perfringens protoxin is selectively cytotoxic to PSA-producing prostate cancer cells. Romanov V; Whyard TC; Waltzer WC; Gabig TG Cancer Lett; 2014 Sep; 351(2):260-4. PubMed ID: 24952257 [TBL] [Abstract][Full Text] [Related]
16. Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells. Singh U; Mitic LL; Wieckowski EU; Anderson JM; McClane BA J Biol Chem; 2001 Sep; 276(36):33402-12. PubMed ID: 11445574 [TBL] [Abstract][Full Text] [Related]
17. Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Czeczulin JR; Hanna PC; McClane BA Infect Immun; 1993 Aug; 61(8):3429-39. PubMed ID: 8335373 [TBL] [Abstract][Full Text] [Related]
18. Role of N-terminal amino acids in the absorption-enhancing effects of the c-terminal fragment of Clostridium perfringens enterotoxin. Masuyama A; Kondoh M; Seguchi H; Takahashi A; Harada M; Fujii M; Mizuguchi H; Horiguchi Y; Watanabe Y J Pharmacol Exp Ther; 2005 Aug; 314(2):789-95. PubMed ID: 15870390 [TBL] [Abstract][Full Text] [Related]
19. Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis. Kokai-Kun JF; Benton K; Wieckowski EU; McClane BA Infect Immun; 1999 Nov; 67(11):5634-41. PubMed ID: 10531210 [TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells. Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]